Australia's most trusted
source of pharma news
Saturday, 28 September 2024
Posted 26 September 2024 AM
After setting out on its own, Sandoz has been working hard to strengthen its culture and champion diversity - and Nic Hennessy has been at the crux of many new initiatives and policies introduced.
Hennessy joined Sandoz one month before the company divested from Novartis to become a standalone generics and biosimilar company after nearly six years at Woolworths, where she held the role of Inclusion Lead.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.